Top

General Thoracic and Cardiovascular Surgery

Published in:

Open Access 01-02-2018 | Current Topics Review Article

Recommendations for perioperative management of lung cancer patients with comorbidities

Authors: Hiroyoshi Tsubochi, Tomoki Shibano, Shunsuke Endo

Published in: General Thoracic and Cardiovascular Surgery | Issue 2/2018

Abstract

Objectives

To improve surgical outcomes, clinicians must provide optimal perioperative care for comorbidities identified as significant factors in risk models for patients undergoing lung cancer surgery.

Methods

We reviewed trends in perioperative care for idiopathic pulmonary fibrosis, cardiovascular diseases, and end-stage renal diseases in patients undergoing lung cancer surgery, as large clinical databases indicate that these comorbidities are significant risk factors for lung cancer surgery. Articles identified by keyword searches were included in the analysis.

Results

Significant predictive factors for acute exacerbation of idiopathic pulmonary fibrosis were identified. However, no effective perioperative care was identified for prevention of acute exacerbation of interstitial pneumonia. The timing of coronary revascularization and antithrombotic management for cardiovascular diseases are subjects of ongoing research, and acid–base balance is essential in the management of hemodialysis patients with end-stage renal diseases.

Conclusions

To improve surgical outcomes for lung cancer patients, future studies should continue to study optimal perioperative management of comorbidities.

Endo S, Ikeda N, Kondo T, Nakajima J, Kondo H, Yokoi K, et al. Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78594 patients during 2014–2015. Eur J Cardiothorac Surg. 2017. doi:https://doi.org/10.1093/ejcts/ezx190.PubMed

Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824. doi: https://doi.org/10.1164/rccm.2009-040GL.CrossRefPubMedPubMedCentral

Juarez MM, Chan AL, Norris AG, Morrissey BM, Albertson TE. Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies. J Thorac Dis. 2015;7:499–519. doi: https://doi.org/10.3978/j.issn.2072-1439.2015.01.17. (Review).PubMedPubMedCentral

Kishaba T, Tamaki H, Shimaoka Y, Fukuyama H, Yamashiro S. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis. Lung. 2014;192:141–9. doi: https://doi.org/10.1007/s00408-013-9530-0. (Epub 2013 Nov 13).CrossRefPubMed

Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K. et.al. Japanese Association for Chest Surgery. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147:1604–1611. (Epub 2013 Nov 20). doi: https://doi.org/10.1016/j.jtcvs.2013.09.050.CrossRefPubMed

Sato T, Kondo H, Watanabe A, Nakajima J, Niwa H, Horio H, et al. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63:164–172. doi: https://doi.org/10.1007/s11748-014-0487-6. (Epub 2014 Oct 30).CrossRefPubMed

Justet A, Laurent-Bellue A, Thabut G, Dieudonné A, Debray MP, Borie R, et al. [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis. Respir Res. 2017;18:74. doi: https://doi.org/10.1186/s12931-017-0556-3.CrossRefPubMedPubMedCentral

Iwata T, Yoshida S, Fujiwara T, Wada H, Nakajima T, Suzuki H, et al. Effect of perioperative pirfenidone treatment in lung cancer patients with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2016;102:1905–10. doi: https://doi.org/10.1016/j.athoracsur.2016.05.094. (Epub 2016 Aug 18).CrossRefPubMed

Iwata T, Yoshino I, Yoshida S, Ikeda N, Tsuboi M, Asato Y, et al. West Japan Oncology Group. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study). Respir Res. 2016;17:90. doi: https://doi.org/10.1186/s12931-016-0398-4.CrossRefPubMedPubMedCentral

10.

Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer., 3rd ed.: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e166S–e190S.CrossRef

11.

García-de-la-Asunción J, García-del-Olmo E, Perez-Griera J, Martí F, Galan G, Morcillo A, et al. Oxidative lung injury correlates with one-lung ventilation time during pulmonary lobectomy: a study of exhaled breath condensate and blood. Eur J Cardiothorac Surg. 2015;48:e37–e44. doi: https://doi.org/10.1093/ejcts/ezv207. (Epub 2015 Jun 18).CrossRef

12.

Mizuno Y, Iwata H, Shirahashi K, Takamochi K, Oh S, Suzuki K, et al. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. Eur J Cardiothorac Surg 2012;41(6):e161–e165. doi:https://doi.org/10.1093/ejcts/ezs147. (Epub 2012 Apr 14).CrossRef

13.

Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, Smith P, et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 2005;3:e174. (Epub 2005 May 3).CrossRefPubMedPubMedCentral

14.

Kim KN, Kim DW, Jeong MA, Sin YH, Lee SK. Comparison of pressure-controlled ventilation with volume-controlled ventilation during one-lung ventilation: a systematic review and meta-analysis. BMC Anesthesiol. 2016;16:72. doi: https://doi.org/10.1186/s12871-016-0238-6.CrossRefPubMedPubMedCentral

15.

Hata A, Suzuki H, Nakajima T, Tanaka K, Fujiwara T, Wada H, et al. Concomitant interstitial lung disease is a risk factor for pleural invasion in lung cancer. Ann Thorac Surg. 2017;103:967–74. (Epub 2016 Oct 17). doi: https://doi.org/10.1016/j.athoracsur.2016.08.074.CrossRefPubMed

16.

Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 2006;81:1028–32.CrossRefPubMed

17.

Ding J, Chen Z, Feng K. Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis. Int J Med Sci. 2013;10:903–7. doi:https://doi.org/10.7150/ijms.4972. Print 2013.CrossRefPubMedPubMedCentral

18.

Wuyts WA, Willems S, Vos R, Vanaudenaerde BM, De Vleeschauwer SI, Rinaldi M, et al. Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model. Exp Lung Res. 2010;36:602–614. (Epub 2010 Sep 27). doi: https://doi.org/10.3109/01902148.2010.492895.CrossRefPubMed

19.

Evans RG, Naidu B. Does a conservative fluid management strategy in the perioperative management of lung resection patients reduce the risk of acute lung injury? Interact Cardiovasc Thorac Surg. 2012;15:498–504. doi:https://doi.org/10.1093/icvts/ivs175. (Epub 2012 May 22. Review).CrossRefPubMedPubMedCentral

20.

Oyama K, Kanzaki M, Kondo M, Maeda H, Sakamoto K, Isaka T, Tamaoki J, Onuki T. Korean J. Thorac Cardiovasc Surg. Early detection of the acute exacerbation of interstitial pneumonia after the surgical resection of lung cancer by planned chest computed tomography. Korean J Thorac Cardiovasc Surg 2017;50:177–83. doi:https://doi.org/10.5090/kjtcs.2017.50.3.177. (Epub 2017 Jun 5).CrossRefPubMedPubMedCentral

21.

Myllärniemi M, Kaarteenaho R. Pharmacological treatment of idiopathic pulmonary fibrosis—preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine. Eur Clin Respir J 2015. doi: https://doi.org/10.3402/ecrj.v2.26385. (eCollection 2015. Review).

22.

Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e278–e333.CrossRef

23.

The Japanese Circulation Society Joint Working Group. Guidelines for perioperative cardiovascular evaluation and management for noncardiac surgery (JCS2014)-Digest Version. Circ J 2017;81:d245–d267.

24.

McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795–2804.CrossRefPubMed

25.

Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR, Hoeks SE, et al. A clinical randomized trial to evaluate the safety of noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V pilot study. J Am Coll Cardiol. 2007;49:1763–9.CrossRefPubMed

26.

Tokushige A, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, et al. Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2. Circ Cardiovasc Interv. 2012;5:237–246.CrossRefPubMed

27.

Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation. 2012;125:584–591.CrossRefPubMed

28.

Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–678.CrossRefPubMed

29.

Kitamura Y, Suzuki K, Teramukai S, Sonobe M, Toyooka S, Nakagawa Y, et al. Feasibility of pulmonary resection for lung cancer in patients with coronary artery disease or atrial fibrillation. Ann Thorac Surg. 2017;103:432–4.CrossRefPubMed

30.

Dyszkiewicz W, Jemielity M, Piwkowski C, Kasprzyk M, Perek B, Gasiorowski L, et al. The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease. Eur J Cardiothorac Surg. 2008;34:531–5.CrossRefPubMed

31.

Berwanger O, Le Manach Y, Suzumura EA, Biccard B, Srinathan SK, Szczeklik W, et al. Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study. Eur Heart J. 2016;37:177–185.CrossRefPubMed

32.

London MJ, Schwartz GG, Hur K, Henderson WG. Association of perioperative statin use with mortality and morbidity after major noncardiac surgery. JAMA Intern Med. 2017;177:231–242.CrossRefPubMed

33.

Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839–47.CrossRefPubMed

34.

Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1494–1503.CrossRefPubMed

35.

Fayad AI, Buamscha DG, Ciapponi A. Intensity of continuous renal replacement therapy for acute kidney injury. Cochrane Database Syst Rev. 2016;10:Cd010613.PubMed

36.

Hanafusa N, Nakai S, Iseki K, Tsubakihara Y. Japanese society for dialysis therapy renal data registry—a window through which we can view the details of Japanese dialysis population. Kidney Int Suppl. 2011;5:15–22. 2015.CrossRef

37.

Saran R, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, et al. US Renal Data System 2016 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2017;69(3S1):A7–A8. doi: https://doi.org/10.1053/j.ajkd.2016.12.004.

38.

Wakasugi M, Kazama JJ, Narita I. Mortality trends among Japanese dialysis patients, 1988–2013: a joinpoint regression analysis. Nephrol Dial Transplant. 2016;31:1501–7.CrossRefPubMed

39.

Gajdos C, Hawn MT, Kile D, Robinson TN, Henderson WG. Risk of major nonemergent inpatient general surgical procedures in patients on long-term dialysis. JAMA Surg. 2013;148:137–143.CrossRefPubMed

40.

Ohta T, Okumura S, Fujioka M, Iuchi K. Pneumonectomy in a case of chronic hemodialysis. Nihon Kyobu Geka Gakkai Zasshi. 1992;40:596–9.PubMed

41.

Yamamoto N, Urabe N. Surgical treatment to the lung cancer in a patient receiving hemodialysis. Kyobu Geka. 1996;49:787–790.PubMed

42.

Tsuchida M, Yamato Y, Aoki T, Watanabe T, Hashimoto T, Shinohara H, et al. Complications associated with pulmonary resection in lung cancer patients on dialysis. Ann Thorac Surg. 2001;71:435–8.CrossRefPubMed

43.

Ciriaco P, Casiraghi M, Melloni G, Carretta A, Libretti L, Augello G, et al. Pulmonary resection for non-small-cell lung cancer in patients on hemodialysis: clinical outcome and long-term results. World J Surg. 2005;29:1516–9.CrossRefPubMed

44.

Yajima K, Urabe N, Asai K. The last period of surgical site infection after pulmonary resection for lung cancer with hemodialysis; report of a case. Kyobu Geka. 2005;58:505–8.PubMed

45.

Obuchi T, Hamanaka W, Yoshida Y, Yanagisawa J, Hamatake D, Shiraishi T, et al. Clinical outcome after pulmonary resection for lung cancer patients on hemodialysis. Ann Thorac Surg. 2009;88:1745–8.CrossRefPubMed

46.

Akiba T, Marushima H, Hiramatsu M, Matsudaira H, Nakanishi K, Takeyama H, et al. Video-assisted thoracoscopic surgery for non-small cell lung cancer in patients on hemodialysis. Ann Thorac Cardiovasc Surg. 2010;16:40–44.PubMed

47.

Takahama M, Yamamoto R, Nakajima R, Tsukioka T, Tada H. Pulmonary resection for lung cancer patients on chronic hemodialysis: clinical outcome and long-term results after operation. Interact Cardiovasc Thorac Surg. 2010;11:150–153. doi:https://doi.org/10.1510/icvts.2009.230003. (Epub 2010 May 31).CrossRefPubMed

48.

Matsuoka K, Kuroda A, Kang A, Imanishi N, Nagai S, Ueda M, et al. Video-assisted thoracoscopic surgery for lung cancer in patients on hemodialysis. Ann Thorac Cardiovasc Surg. 2013;19:263–7. (Epub 2012 Nov 15).CrossRefPubMed

49.

Caroli G, Dolci G, Dell’Amore A, Asadi N, Greco D, Chadi A, et al. Video-assisted thoracoscopic lobectomy for non-small cell lung cancer: a morbidity limiting approach in a patient on chronic hemodialysis and double agent antiplatelet therapy. Gen Thorac Cardiovasc Surg. 2015;63:177–180.CrossRefPubMed

50.

Park BJ, Shin S, Kim HK, Choi YS, Kim J, Shim YM. Surgical treatment for non-small cell lung cancer in patients on hemodialysis due to chronic kidney disease: clinical outcome and intermediate-term results. Korean J Thorac Cardiovasc Surg. 2015;48:193–8.CrossRefPubMedPubMedCentral

51.

Schreiber S, Korzets A, Powsner E, Wolloch Y. Surgery in chronic dialysis patients. Isr J Med Sci. 1995;31:479–483.PubMed

52.

Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant. 1994;9:1136–42.CrossRefPubMed

53.

Reque J, Garcia-Prieto A, Linares T, Vega A, Abad S, Panizo N, et al. Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in haemodialysis patients. Nephrology (Carlton). 2016;21:321–6.CrossRef

54.

Ito T, Maekawa H, Sakurada M, Orita H, Kushida T, Senuma K, et al. Risk factors for postoperative complications in patients on maintenance hemodialysis who undergo abdominal surgery. Asian J Surg. 2016;39:211–7.CrossRefPubMed

55.

Oettinger CW, Oliver JC. Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate. J Am Soc Nephrol. 1993;3:1804–7.PubMed

56.

Park CM, Chun HK, Jeon K, Suh GY, Choi DW, Kim S. Factors related to post-operative metabolic acidosis following major abdominal surgery. ANZ J Surg. 2014;84:574–580.CrossRefPubMed

57.

Silva JM Jr, de Oliveira Ribas Rosa, Mendes Nogueira AM, Vianna FA, Amendola PM, Carvalho Carmona CP. MJ, et al. Metabolic acidosis assessment in high-risk surgeries: prognostic importance. Anesth Analg. 2016;123:1163–71.CrossRefPubMed

58.

Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5–14.CrossRefPubMed

59.

Leunissen KM, Kouw P, Kooman JP, Cheriex EC, deVries PM, Donker AJ, et al. New techniques to determine fluid status in hemodialyzed patients. Kidney Int Suppl. 1993;41:S50–S56.

60.

Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manag. 2004;28:497–504.CrossRef

61.

Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37:783–805.CrossRefPubMed

62.

Allegranzi B, Zayed B, Bischoff P, Kubilay NZ, de Jonge S, de Vries F, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16:e288–e303. doi: https://doi.org/10.1016/S1473-3099(16)30402-9. (Epub 2016 Nov 2).

63.

Vijayan M, Radhakrishnan S, Abraham G, Mathew M, Sampathkumar K, Mancha NP. Diabetic kidney disease patients on hemodialysis: a retrospective survival analysis across different socioeconomic groups. Clin Kidney J. 2016;9:833–8.CrossRefPubMedPubMedCentral

Title: Recommendations for perioperative management of lung cancer patients with comorbidities
Authors: Hiroyoshi Tsubochi
Tomoki Shibano
Shunsuke Endo
Publication date: 01-02-2018
Publisher: Springer Japan
Published in: General Thoracic and Cardiovascular Surgery / Issue 2/2018
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI: https://doi.org/10.1007/s11748-017-0864-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Recommendations for perioperative management of lung cancer patients with comorbidities

Abstract

Objectives

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2018

Thoracoscopic resection of esophageal cancer with a tracheal diverticulum

Postoperative atrial fibrillation is less frequent in pulmonary segmentectomy compared with lobectomy

VATS segmentectomy: past, present, and future

A novel technique of total debranching TEVAR with inflow from the descending aorta

Efficacy of a sheet combined with fibrin glue in repair of pleural defect at the early phase after lung surgery in a canine model

Cardiopulmonary bypass for pediatric cardiac surgery